M. Castro

Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial. Preliminary report.

F. Pelorosso, F. Azzato, R. Rothlin, 2020, medRxiv.

Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase 3 IMspire170 study.

K. Flaherty, J. Larkin, H. Gogas, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial

F. Pelorosso, F. Azzato, R. Rothlin, 2021, EClinicalMedicine.

Effect of Ivermectin 600 mcg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial

C. Lindsell, D. Boulware, M. Sulkowski, 2022, medRxiv.

Efficacy and safety of lebrikizumab (an anti‐IL‐13 monoclonal antibody) in adults with moderate‐to‐severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo‐controlled phase II trial (TREBLE)

C. Flohr, T. Omachi, T. Bieber, 2018, Journal of the American Academy of Dermatology.